![Michael D. Waterfield](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Michael D. Waterfield
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Piramed Ltd.
![]() Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK.
9
| Subsidiary | Miscellaneous Commercial Services | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michael D. Waterfield via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
CellCentric Ltd.
![]() CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
The University of Nottingham | College/University | Doctorate Degree Doctorate Degree | |
VERNALIS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Samsara Biocapital LLC
![]() Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Chugai Pharma USA LLC
![]() Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a company that develops safe and effective drugs. The company is based in Bedminster, NJ. | Medical Distributors | Corporate Officer/Principal | |
Karus Therapeutics Ltd.
![]() Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
The University of Liverpool
![]() The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree | |
Celltech Chiroscience Plc
![]() Celltech Chiroscience Plc Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Celltech Chiroscience Plc is a research-based pharmaceutical group. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cancer Research UK
![]() Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of Manchester | College/University | Corporate Officer/Principal | |
Hox Therapeutics Ltd.
![]() Hox Therapeutics Ltd. BiotechnologyHealth Technology Hox Therapeutics Ltd. develops therapeutics for cancer diseases based on the role of HOX genes. The private company is based in Guildford, UK. | Biotechnology | Director/Board Member | |
Autobahn Labs, Inc.
![]() Autobahn Labs, Inc. Medical/Nursing ServicesHealth Services Autobahn Labs, Inc. is a virtual incubator that partners with research institutions to accelerate the advancement of early-stage drug discovery and development. The company is based in Palo Alto, CA. The organization invests intellectual, financial, and physical capital to efficiently move projects from feasibility to novel drug candidates. Autobahn Labs was created by Samsara Biocapital, Evotec, and KCK Ltd. | Medical/Nursing Services | Consultant / Advisor | |
Nalo Therapeutics, Inc.
![]() Nalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nalo Therapeutics, Inc. is a company that focuses on developing therapeutics to address unmet needs in cancer. Nalo Therapeutics is based in Belmont, CA and the CEO of the company is Keith Wilson. The company targets oncogenic driver mutations and/or proteins that are often difficult to drug. The company was founded in 2017 and collaborates with UCSF scientific cofounders. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University College London | College/University | Corporate Officer/Principal | |
University of Bristol | College/University | Undergraduate Degree | |
ReOx Ltd.
![]() ReOx Ltd. Pharmaceuticals: MajorHealth Technology ReOx Ltd. discovers and develops drugs. It provides novel treatments for disease by controlling the actvity of hypoxia inducible factor. The company was founded by Christopher W. Pugh, Patrick Maxwell, Peter J. Ratcliffe, and Christopher J. Schofield in June 2003 and is headquartered in Thame, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
OSI Pharmaceuticals (UK) Ltd. | Corporate Officer/Principal | ||
University of Kent | College/University | Undergraduate Degree | |
Oxford Brookes University | College/University | Masters Business Admin | |
Cancer Research Technology Ltd.
![]() Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Corporate Officer/Principal | |
BERGENBIO ASA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Royal College of Physicians | College/University | Corporate Officer/Principal | |
Ludwig Institute for Cancer Research Ltd.
![]() Ludwig Institute for Cancer Research Ltd. Medical/Nursing ServicesHealth Services Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY. | Medical/Nursing Services | Corporate Officer/Principal | |
Macrophage Pharma Ltd.
![]() Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Biotechnology | Chairman | |
APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
Asterion Ltd.
![]() Asterion Ltd. BiotechnologyHealth Technology Asterion Ltd. develops novel therapeutic products. It offers drugs for patients with chronic, debilitating diseases. The company was founded by Richard John Martin Ross, Peter Artymiuk and Jon R. Sayers in 2001 and is headquartered in Sheffield, the United Kingdom. | Biotechnology | Chairman | |
Oxford BioTherapeutics Ltd.
![]() Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Akamis Bio Ltd.
![]() Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman | |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
Phogen Ltd. | Chairman | ||
Chronos Therapeutics Ltd.
![]() Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman | |
Akinion Pharmaceuticals AB
![]() Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman | |
Mironid Ltd.
![]() Mironid Ltd. Pharmaceuticals: MajorHealth Technology Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
STORM Therapeutics Ltd.
![]() STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Imperial College London | College/University | Doctorate Degree | |
Wellcome Research Laboratories | Corporate Officer/Principal | ||
American Society for Microbiology
![]() American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigd Koninkrijk | 34 |
Verenigde Staten | 11 |
Canada | 5 |
Noorwegen | 2 |
Zweden | 2 |
Sectoraal
Health Technology | 27 |
Consumer Services | 10 |
Commercial Services | 7 |
Health Services | 3 |
Finance | 2 |
Operationeel
Corporate Officer/Principal | 25 |
Director/Board Member | 13 |
Chief Tech/Sci/R&D Officer | 11 |
Chairman | 11 |
Doctorate Degree | 7 |
Sterkste connecties
Insiders | |
---|---|
Michael G. Moore | 16 |
Stephen Shuttleworth | 13 |
Anthony Brown | 10 |
David B. Knowles | 9 |
Neil Pegg | 7 |
Paul Workman | 5 |
Simon Long | 4 |
Stephane Jallat | 3 |
Peter Parker | 3 |
- Beurs
- Insiders
- Michael D. Waterfield
- Bedrijfsconnecties